Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia
Not Applicable
Recruiting
- Conditions
- Postoperative Pain
- Interventions
- Other: Spinal anesthesiaDrug: Intrathecal nalbuphine and spinal anesthesiaOther: US-guided fascia iliaca compartment block (FICB) and spinal anesthesia
- Registration Number
- NCT06818396
- Lead Sponsor
- Ain Shams University
- Brief Summary
It is already known that fascia iliaca compartment block and intrathecal nalbuphine are very effective ways in postoperative pain control in patients having hip surgeries.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- American Society of Anesthesiologists (ASA) score (ASA I- ASA II).
- Age ≥ 21years.
- Body mass index < 35 kg/m2
Exclusion Criteria
- Patient's refusal.
- Known coagulopathy.
- Known peripheral neuropathy or neurological deficits.
- Known allergy to study drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Spinal anesthesia Spinal anesthesia - Intrathecal nalbuphine and spinal anesthesia Intrathecal nalbuphine and spinal anesthesia - US-guided fascia iliaca compartment block (FICB) and spinal anesthesia US-guided fascia iliaca compartment block (FICB) and spinal anesthesia -
- Primary Outcome Measures
Name Time Method Time to first rescue analgesia (minutes). in the first 24 hours after surgery Time to first rescue analgesia (minutes).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie FICB's analgesic effects compared to intrathecal nalbuphine in hip surgery?
How does FICB compare to intrathecal nalbuphine in opioid consumption and pain scores after hip surgery under spinal anesthesia?
Which biomarkers correlate with improved analgesic outcomes in FICB versus intrathecal nalbuphine for postoperative hip pain?
What are the safety profiles and management strategies for FICB-related complications versus nalbuphine-induced opioid side effects in hip surgery?
Are there alternative adjuvants or combination therapies to FICB and intrathecal nalbuphine for enhancing postoperative analgesia in hip surgery?
Trial Locations
- Locations (1)
Ain-Shams University Hospitals
🇪🇬Cairo, Egypt
Ain-Shams University Hospitals🇪🇬Cairo, EgyptIbrahim Mamdouh EsmatContact01001241928ibrahim_mamdouh@med.asu.edu.eg